Value
5.5/10data confidence 83%| Component | Sub-score |
|---|---|
| P/E | 8.1 |
| P/S | 8.3 |
| EV/EBITDA | 5.3 |
| Fwd P/E | 5.7 |
| Analyst target | 3.0 |
- ▸Forward P/E: 22.6x
RLI · Why this verdict
Why RLI (RLI) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score4.8/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
RLI has beaten earnings estimates in each of the last four consecutive quarters with an average positive surprise of 12%, reflecting consistent underwriting discipline and pricing power in specialty insurance lines. Earnings | The beat streak extends to six or more consecutive quarters as specialty insurance pricing continues to benefit from industry-wide reinsurance tightening. | →Stable |
| CounterA perfect beat streak often means analyst estimates have been deliberately set conservatively; the true earnings trajectory may be flatter than the beat pattern implies. | ||
Net margins of 21%, a Piotroski F-Score of 7 out of 9, and a quality peer rank of 7.8 out of 10 place RLI among the best-run insurers in its peer group, supporting premium valuation over the medium term. Quality breakdown | Operating margins remain above 18% over the next four quarters as pricing discipline is maintained in specialty lines. | →Stable |
| CounterFree cash flow is only 20% of net income, indicating earnings quality concerns where reported profits are not converting to cash at the same rate. | ||
The current price of $53.59 is already at the resistance target of $53.75, producing negative upside of -8.4% relative to analyst consensus, meaning the stock offers no margin of safety for new buyers at current levels. Warnings | Analyst consensus price targets rise above $62 within 12 months as earnings growth is revised upward, restoring a positive risk-reward profile. | →Stable |
| CounterThe stock trading near analyst targets is a sign of recognition, not a ceiling; continued operational excellence can drive target upgrades that create a new entry window. | ||
Despite improving MACD, the stock is trading below its 200-day moving average with a slope of -3.1% over 30 days, signaling a confirmed downtrend that historically precedes further price weakness before a recovery. Momentum breakdown | Price reclaims the 200-day moving average and holds above it for at least 30 consecutive days, confirming the technical downtrend has reversed. | →Stable |
| CounterFor a quality insurer with a perfect beat streak, technical weakness often reflects broader sector rotation rather than fundamental deterioration, creating a potential entry opportunity for patient investors. | ||
RLI has beaten earnings estimates in each of the last four consecutive quarters with an average positive surprise of 12%, reflecting consistent underwriting discipline and pricing power in specialty insurance lines.
→StableEarnings
- Expectation
- The beat streak extends to six or more consecutive quarters as specialty insurance pricing continues to benefit from industry-wide reinsurance tightening.
CounterA perfect beat streak often means analyst estimates have been deliberately set conservatively; the true earnings trajectory may be flatter than the beat pattern implies.
Net margins of 21%, a Piotroski F-Score of 7 out of 9, and a quality peer rank of 7.8 out of 10 place RLI among the best-run insurers in its peer group, supporting premium valuation over the medium term.
→StableQuality breakdown
- Expectation
- Operating margins remain above 18% over the next four quarters as pricing discipline is maintained in specialty lines.
CounterFree cash flow is only 20% of net income, indicating earnings quality concerns where reported profits are not converting to cash at the same rate.
The current price of $53.59 is already at the resistance target of $53.75, producing negative upside of -8.4% relative to analyst consensus, meaning the stock offers no margin of safety for new buyers at current levels.
→StableWarnings
- Expectation
- Analyst consensus price targets rise above $62 within 12 months as earnings growth is revised upward, restoring a positive risk-reward profile.
CounterThe stock trading near analyst targets is a sign of recognition, not a ceiling; continued operational excellence can drive target upgrades that create a new entry window.
Despite improving MACD, the stock is trading below its 200-day moving average with a slope of -3.1% over 30 days, signaling a confirmed downtrend that historically precedes further price weakness before a recovery.
→StableMomentum breakdown
- Expectation
- Price reclaims the 200-day moving average and holds above it for at least 30 consecutive days, confirming the technical downtrend has reversed.
CounterFor a quality insurer with a perfect beat streak, technical weakness often reflects broader sector rotation rather than fundamental deterioration, creating a potential entry opportunity for patient investors.
TrendMatrix Research · core thesis
Engine thesis — one sentence
RLI Corp. is a specialty property and casualty insurer with a perfect four-quarter earnings beat streak and best-in-class margins, but the stock has already reached analyst price targets with negative implied upside, making it a hold rather than a compelling new entry.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
5.6/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 7.7 |
| ROA | 3.5 |
| Gross margin | 2.7 |
| Op margin | 6.4 |
| Net margin | 10.0 |
| Current ratio | 4.7 |
| FCF quality | 1.6 |
| Moat | 6.4 |
| Piotroski F | 7.8 |
- ▸Strong margins: 21%
- ▸Earnings quality RED FLAG: 20% FCF/NI
- ▸Strong Piotroski F-Score: 7/9
Growth
1.8/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 3.5 |
| EPS growth | 0.0 |
Momentum
6.9/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.1 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 7.5 |
| Volume | 2.9 |
- ▸Overbought (RSI 77)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-MA but MA slope flat/negative + RSI 77 (late-cycle distribution risk)
Sentiment
4.7/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 4.2 |
| erm sentiment | 5.0 |
Insider
5.3/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.5 |
| holder change | 5.1 |
- ▸Insider buying (low materiality) — $1,118,955 (0.019% of mkt cap)
Peer rank
3.3/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 2.1 |
| quality rank | 7.4 |
| growth rank | 3.6 |
Technical
2.8/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.2 |
| support resistance | 0.7 |
| 52w position | 7.4 |
Risk (lower is worse)
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 6.0 |
| days to cover | 4.0 |
| volatility | 6.4 |
| put call | 10.0 |
| implied vol | 0.0 |
| beta | 10.0 |
| debt equity | 9.2 |
- ▸High IV: 134%
Catalyst
7.1/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 8.5 |
| dividend safety | 7.0 |
- ▸Perfect beat streak: 4Q
- ▸Dividend: 115.0%
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (7)
- MOMENTUM:6.9>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:17d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-1.3=NEGATIVE
Warning (1)
- DEATH_CROSS:momentum=6.9>=5.0 recovering
Reward-to-Risk
-1.32
Upside
-19.9%
Downside
15.0%
Sizing output
AVOID
SetupRecovery — Death cross but MACD improving, RSI 77
EdgeCatalyst-Driven — Earnings in 17d with 4/4 beat streak
SuitabilitySpeculative — Binary industry: Insurance - Property & Casualty
Investment implication
The F-path SELL output reflects an overall score of 4.8 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Catalyst at 7.1) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-1.3=NEGATIVE) reinforce the read. Current asymmetry R:R is -1.32 — supplementary context, not the trigger for this path.
The strongest dimensions are Catalyst at 7.1, Momentum at 6.9, and Risk (lower is worse) at 6.5; the weakest are Growth at 1.8, Technical at 2.8, and Peer rank at 3.3. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -1.32 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Earnings Beat Streak Underwriting
Trip ifEPS surprise falls below 0% in at least 2 of the next 4 quarters, breaking the current beat streak.
- P2Best In Class Margins
Trip ifNet margin falls below 15% in any reported quarter, indicating underwriting discipline has deteriorated.
- P3Price At Analyst Target Negative Asymmetry
Trip ifPrice rises above $62 without a corresponding analyst target upgrade, creating more than 15% downside to consensus targets.
- P4Momentum Death Cross Technical Risk
Trip ifPrice drops below $48, more than 10% below the current $53.59, confirming the death cross is driving sustained selling rather than a temporary pullback.